Longitudinal untargeted metabolomics of cognitive impairment in Parkinson's disease
Alzheimer's & Dementia · 2026-10 · 22 (10)
DOI: 10.1002/alz.71890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 06.10.2026. Verfasst von Yuyuan Lin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Metabolomics, Cognitive Dysfunction, Metabolome. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: U.S. Department of Defense (DoD), NIA NIH HHS, NIEHS NIH HHS.
Abstract (Originalsprache)
INTRODUCTION Cognitive impairment is a common non‐motor symptom of Parkinson's disease (PD), yet the mechanism remains unclear. METHODS Longitudinal serum samples from PD patients in a community‐based case–control study were profiled, with cognition assessed by the Mini‐Mental State Examination at baseline and follow‐up. We performed three metabolome‐wide association studies: a baseline cross‐sectional analysis ( n = 632), a time‐to‐event analysis ( n = 412), and a repeated measures analysis ( n = 265), followed by “Mummichog” pathway analysis. RESULTS Of the 4762 metabolomic features, four reached statistical significance in the baseline analysis, 22 in the time‐to‐event analysis, and none in the repeated measures analysis. Dysregulated pathways included purine metabolism, the pentose phosphate pathway, fatty acid pathways, and C21‐steroid hormone biosynthesis and metabolism. DISCUSSION Disruptions in core metabolic pathways may contribute to PD‐related cognitive impairments. Disturbances in pentose and purine pathways may occur before clinical cognitive decline is observed, suggesting early metabolic markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA.
- Center for Health Policy Research, UCLA Fielding School of Public Health, Los Angeles, California, USA.
- Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
- Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.
- Gangarosa Department of Environmental Health, Emory University School of Medicine, Atlanta, Georgia, USA.
- Department of Neurology, UCLA Fielding School of Public Health, Los Angeles, California, USA.
ORCID-Profile: Yuyuan Lin
Förderung
- U.S. Department of Defense (DoD)
- NIA NIH HHS
- NIEHS NIH HHS
- National Institute of Environmental Health Sciences (NIEHS)
- National Institute on Aging
Zitieren
APA
Lin, Y., Yu, Y., Zhang, K., Del Rosario, I., Duarte Folle, A., Mayeda, E. R., Jones, D. P., Walker, D. I., Bronstein, J., Keener, A. M., Paul, K. C., & Ritz, B. (2026). Longitudinal untargeted metabolomics of cognitive impairment in Parkinson's disease. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71890
Vancouver
Lin Y, Yu Y, Zhang K, Del Rosario I, Duarte Folle A, Mayeda ER, et al. Longitudinal untargeted metabolomics of cognitive impairment in Parkinson's disease. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71890
BibTeX
@article{Lin2026,
author = {Lin, Yuyuan and Yu, Yu and Zhang, Keren and Del Rosario, Irish and Duarte Folle, Aline and Mayeda, Elizabeth Rose and Jones, Dean P and Walker, Douglas I and Bronstein, Jeff and Keener, Adrienne M and Paul, Kimberly C and Ritz, Beate},
title = {Longitudinal untargeted metabolomics of cognitive impairment in Parkinson's disease},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {10},
doi = {10.1002/alz.71890}
}
EUVIMED